Breaking news! Venclexta (ABT-199) was just approved for CLL patients with 17 P deletion. Stay tuned for an expert interview for more information soon! In the meantime, learn more about the research that led to the drug approval here-patientpower.info/video/are...
FDA annoucement- fda.gov/NewsEvents/Newsroom...
Get the conversation going! Comment your thoughts about this exciting announcement, if you've taken this drug before in a clinical trial or if you have 17 P deletion!
